Clinical Trials for PCOS: Treatment Studies and Resources

·

Polycystic ovary syndrome (PCOS) affects approximately 6-12% of women of reproductive age and has been historically underfunded relative to its prevalence and impact. Recent research has expanded with GLP-1 receptor agonists addressing the metabolic features, novel approaches to hyperandrogenism, and improved understanding of subtypes. For PCOS patients, clinical trials for pcos offer access to investigational therapies. This guide covers how to find PCOS trials, active research areas, and resources.

Categories of PCOS trials

Active PCOS trials in 2026 include:

GLP-1 receptor agonists: Trials testing semaglutide and other GLP-1s in PCOS for weight loss, insulin resistance, and ovulation.

Inositol formulations: Myo-inositol and D-chiro-inositol combinations for metabolic features.

Anti-androgen approaches: Beyond spironolactone, novel anti-androgen mechanisms.

Fertility approaches: Optimal protocols for ovulation induction and assisted reproduction in PCOS.

Metabolic syndrome targeting: Combinations addressing insulin resistance, dyslipidemia.

Lifestyle and behavioral interventions: Structured programs targeting weight loss and metabolic health.

Where to find PCOS trials

Resources:

  • ClinicalTrials.gov
  • PCOS Awareness Association
  • Major academic reproductive endocrinology programs

Typical eligibility

Common inclusion criteria:

  • PCOS diagnosis meeting Rotterdam criteria
  • Specific metabolic or hormonal features depending on trial
  • Reproductive age

Common exclusion criteria:

  • Pregnancy or planned pregnancy (for non-fertility trials)
  • Other endocrine disorders
  • Significant medical conditions

Frequently Asked Questions

Are PCOS GLP-1 trials available?

Yes, with multiple trials testing GLP-1s for various PCOS features.

Can I be in a PCOS trial while trying to conceive?

Some fertility-focused trials specifically address this; others require contraception.

Are inositol trials worthwhile?

Some evidence supports benefit for metabolic features. Trials continue to refine the role.

What about adolescent PCOS trials?

Less common but increasing. Diagnosis in adolescents has specific considerations.

How long do PCOS trials typically last?

3-12 months for metabolic outcomes; longer for fertility outcomes.

The bottom line on PCOS trials

PCOS research is expanding with GLP-1s, novel anti-androgens, and metabolic targeting. Academic reproductive endocrinology programs provide trial resources.

Medical Disclaimer: The information in this article is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making any health-related decisions.

Related Articles